Citation Impact
Citing Papers
Rice consumption contributes to arsenic exposure in US women
2011
Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
2014
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Algae as nutritional and functional food sources: revisiting our understanding
2016 Standout
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen
2013
DNA methylation arrays as surrogate measures of cell mixture distribution
2012 Standout
Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: Review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh
2009
Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group
2016 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global patterns and trends in colorectal cancer incidence and mortality
2016 Standout
Diabetes and risk of bladder cancer
2010
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Arsenic in groundwaters in the Northern Appalachian Mountain belt: A review of patterns and processes
2008
Current perspectives in muscle invasive bladder cancer
2002
The health effects of exposure to arsenic-contaminated drinking water: a review by global geographical distribution
2014
Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study
2011
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
2017
Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents
2014
Raloxifene Inhibits Growth of RT4 Urothelial Carcinoma Cells via Estrogen Receptor-Dependent Induction of Apoptosis and Inhibition of Proliferation
2012
Guidelines on Bladder Cancer
2002
A review of soil heavy metal pollution from industrial and agricultural regions in China: Pollution and risk assessment
2018 Standout
Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
2011
Aspirin and cancer risk: a quantitative review to 2011
2012
Tissue characterization using electrical impedance spectroscopy data: a linear algebra approach
2012
Colorectal cancer
2013 Standout
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
2006
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Bladder Preservation Strategies
2014
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Distressful symptoms after radical radiotherapy for urinary bladder cancer
2002
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Arsenic: Extension of its Endocrine Disruption Potential to Interference with Estrogen Receptor-Mediated Signaling
2007
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2023
Cancer treatment and survivorship statistics, 2012
2012 Standout
Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case–control study
2011
Total and specific fluid consumption as determinants of bladder cancer risk
2005
The role of antisense oligonucleotides in the treatment of bladder cancer
2002
Arsenic Exposure and Toxicology: A Historical Perspective
2011
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
2015
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
2013
The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients
2015
Lymphedema beyond breast cancer
2010 Standout
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
2007 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Prediabetes: a high-risk state for diabetes development
2012 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Arsenic species in seafood: Origin and human health implications
2010
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
2009
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem
2013 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Bladder Cancer
2020 Standout
Developmentally Restricted Genetic Determinants of Human Arsenic Metabolism: Association between Urinary Methylated Arsenic and CYT19 Polymorphisms in Children
2005
Arsenic in Drinking Water and Risk of Urinary Tract Cancer: A Follow-up Study from Northeastern Taiwan
2010
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Rice Consumption and Urinary Arsenic Concentrations in U.S. Children
2012
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Arsenic as an Endocrine Disruptor: Arsenic Disrupts Retinoic Acid Receptor–and Thyroid Hormone Receptor–Mediated Gene Regulation and Thyroid Hormone–Mediated Amphibian Tail Metamorphosis
2007
11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
2013
Drinking-Water Arsenic Exposure Modulates Gene Expression in Human Lymphocytes from a U.S. Population
2008
Global Water Pollution and Human Health
2010 Standout
DNA Methylation Array Analysis Identifies Profiles of Blood-Derived DNA Methylation Associated With Bladder Cancer
2011
Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
2011
Utility of Recent Studies to Assess the National Research Council 2001 Estimates of Cancer Risk from Ingested Arsenic
2010
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of John Heaney being referenced
Glucocorticoid therapy and risk of bladder cancer
2009
Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study
2007
Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
1996
Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12
1993
Incidence of Transitional Cell Carcinoma of the Bladder and Arsenic Exposure in New Hampshire
2004
Genetic and least squares algorithms for estimating spectral EIS parameters of prostatic tissues
2008
Parity, early menopause and the incidence of bladder cancer in women: A case–control study and meta-analysis
2010
Electrical Properties of Prostatic Tissues: II. Spectral Admittivity Properties
2009